We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




World’s First Capsule Endoscopy System with Four Cameras Provides Comprehensive 360° Panoramic Imaging

By HospiMedica International staff writers
Posted on 17 Jan 2025

For years, families and healthcare providers have struggled with the limitations of traditional capsule endoscopy systems, which rely on outdated technology. More...

These systems, with only one forward-facing camera, offer a narrow "tunnel" view of the small bowel, increasing the risk of missing lesions. Additionally, children undergoing these procedures have often been required to endure uncomfortable equipment during the examination. Now, the only capsule endoscopy system featuring comprehensive 360° panoramic imaging and no wearable equipment is available for pediatric patients, offering a gentler, stress-free alternative to traditional capsule endoscopy procedures.

CapsoVision’s (Saratoga, CA, USA) CapsoCam Plus has received FDA clearance for use in pediatric patients aged two and older, providing children with a non-invasive, comfortable diagnostic option that reduces the stress associated with traditional capsule endoscopy procedures. CapsoCam Plus is the only system with four cameras that capture a 360° panoramic lateral view of the small bowel and any abnormalities in high resolution. This allows physicians to view the mucosa directly where abnormalities are located, rather than relying on the limited "tunnel" view of previous systems, improving lesion detection. Additionally, CapsoCam Plus eliminates the need for children to wear any equipment, such as recorders, sensor belts, vests, or other devices attached to the body with adhesive strips. This removes the complications of dealing with broken or disconnected devices and the need for families to return equipment after the procedure a—common challenges with traditional systems.

Instead, CapsoCam Plus provides unmatched convenience for pediatric patients, allowing them to swallow the capsule without being fitted with any additional equipment, reducing the anxiety associated with the procedure. Once ingested, pediatric patients can resume their normal daily activities while the medical practice focuses on providing quality care for other patients. The user-friendly design of the FDA-cleared retrieval system simplifies the process of confirming capsule passage and collection, making it less prone to errors. This system gives peace of mind, ensuring that the capsule has been eliminated, thereby preventing the need for additional testing, such as X-rays, to confirm its passage. Healthcare providers can also use CapsoCloud, CapsoVision's advanced cloud-based software, to easily access diagnostic results online, streamlining the process and improving efficiency for gastroenterologists, nurses, and other staff.

"With the clearance of CapsoCam Plus for pediatric use for patients aged two and above, we can now extend these offerings to our most vulnerable population, ensuring they receive the care and attention they need,’ said Johnny Wang, President and CEO of CapsoVision. “CapsoCam is a child-friendly solution that significantly improves patient, parent, and provider experience while enhancing clinical accuracy and diagnostic confidence."

"The elimination of cumbersome equipment not only increases comfort, privacy, and mobility for pediatric patients, but also reduces anxiety and fear, letting children feel less like patients and more like themselves, free to play and enjoy their day," said Doug Atkinson, Senior Vice President at CapsoVision. "CapsoCam Plus is more than just a medical advancement; it's about empowering families to take control of their child's healthcare journey while ensuring that healthcare providers can deliver high-quality care more efficiently."

Related Links:
CapsoVision


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Lateral Lumbar Interbody Spacer
CALIBER-L
New
Trocar
TAN RoTaLock Trocar
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.